Image Sourced Clinica Las Americas
The Market Herald - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • IMEXHS Limited has announced a major new contract with Promotora Medica De Las Americas, a privately owned hospital in Columbia.
  • It is set to service more than 340 patients and employs 500 medical staff

Founded in 2012 IMEXHS is a leading imaging software and ancillary solutions provider and is known for its flexible and scalable imaging solutions.

IMEXHS offers a range of products such as the OmniLoop which integrates information about the company, important people, contacts, news and documents onto an integrated platform.

It allows for the ease in downloading, saving, sharing and viewing announcements in a clean and organised way.

OmniCorp allows unlisted companies to meet regulatory, governance and compliance requirements. It also assists in the companies to meet digital communication requirements and feedback from stakeholders.

OmniPeople is an employee engagement and management product designed to suit the specific requirements of the organisation’s stakeholder needs. It offers the ability to provide simple tasks from documents and the news and make them more complex.

It also offers training to new employees, health and safety surveys and monitoring the payroll.

OmniMember is a membership based product that offers and allows digital stakeholders engagements for clubs, organisations and anything with a large customer base.

Based in Columbia Clinica Las Americas offers a modern and specialised hospital which specialises in medical imaging services, intensive care, neonatal care and microbiological protection. It has more than 340 beds and more than 500 specialists on hand.

This renewal extends and expands on the existing managing services contract with Clinica Las Americas for a further six years. This contract will also introduce the first Vendor Neutral Archive integrated cardiology module from IMEXHS.

This will help productivity and workflow improvements in the hospital and enhance the technology, functionality and quality of diagnosis in the medical imaging services.

IMEXHS CEO Dr German Arango is pleased with the extension.

“The extension of this contract demonstrates the confidence and strength of the relationship with one of our most important customers and represents the expanding capabilities of our products to support the growing operations of one of the best clinics in the region,” he said.

IME by the numbers
More From The Market Herald

The Calmer Co locks in $700k in funding via convertible note issue

The Calmer Co (ASX:CCO) has confirmed its receipt of $700,000 in funding from existing shareholders.

FDA greenlights Botanix Pharmaceuticals’ Sofdra resubmission plan

FDA approves Botanix's strategy for Sofdra NDA resubmission with no additional materials requested, keeping submission to…

Botanix Pharmaceuticals successfully closes $13.5m Placement to boost US commercial activities

Botanix Pharmaceuticals (ASX: BOT) has closed its $13.5 million placement to both new and existing institutional…

Pharmaust completes Phase One Monepantel study and files for Orphan Drug Designation

Pharmaust (ASX:PAA) has announced that all patients have completed its phase one MEND study using monepantel…